Regulation of the Acute Phase and Immune Responses in Viral Disease. Enhanced Expression of the Beta 2-interferon/hepatocyte-stimulating Factor/interleukin 6 Gene in Virus-infected Human Fibroblasts
Overview
General Medicine
Affiliations
We have defined the expression of the mRNA for, and secretion of, IFN-beta 2/hepatocyte-stimulating factor/IL-6 (IFN-beta 2/IL-6) in human diploid fibroblasts (FS-4 strain) infected with different RNA- and DNA-containing viruses. RNA blot-hybridization analyses carried out 6-8 h after the beginning of infection showed that the RNA-containing Sendai virus (paramyxoviridae) enhanced IFN-beta 2/IL-6 mRNA levels 10-fold, followed, in decreasing order, by encephalomyocarditis (EMC, picornaviridae), vesicular stomatitis (VSV, rhabdoviridae), Newcastle disease virus (NDV, paramyxoviridae), and influenza A (Flu, myxoviridae) viruses. The DNA-containing pseudorabies virus (PR, herpesviridae) enhanced IFN-beta 2/IL-6 mRNA levels sixfold, while the effect of adenovirus type 5 (Ad5, adenoviridae) was considerably less and comparable with that of NDV or Flu. A rabbit antiserum raised against E. coli-derived human IFN-beta 2/IL-6 was used in immunoprecipitation experiments to monitor the secretion of 35S-methionine-pulse-labeled IFN-beta 2/IL-6 proteins by fibroblasts up to 7 h after the beginning of infection. Enhanced levels of secretion of IFN-beta 2/IL-6 (2-14-fold) were observed in every instance evaluated (Sendai, EMC, VSV, Flu, PR, Ad5 viruses). A biological consequence of enhanced secretion of IFN-beta 2/IL-6 was the ability of media from infected FS-4 cell cultures to enhance by 8-15-fold the synthesis and secretion of a typical acute phase plasma protein (alpha 1-antichymotrypsin) by human hepatoma Hep3B2 cells. These observations make it likely that IFN-beta 2/IL-6 mediates, in part, the host response to acute virus infections.
Diagnostic value of IL-6 for patients with asthma: a meta-analysis.
Pan R, Kuai S, Li Q, Zhu X, Wang T, Cui Y Allergy Asthma Clin Immunol. 2023; 19(1):39.
PMID: 37173781 PMC: 10182700. DOI: 10.1186/s13223-023-00794-3.
Karwaciak I, Karas K, Salkowska A, Pastwinska J, Ratajewski M Molecules. 2022; 27(12).
PMID: 35744777 PMC: 9228867. DOI: 10.3390/molecules27123651.
Interleukin-6: obstacles to targeting a complex cytokine in critical illness.
McElvaney O, Curley G, Rose-John S, McElvaney N Lancet Respir Med. 2021; 9(6):643-654.
PMID: 33872590 PMC: 8051931. DOI: 10.1016/S2213-2600(21)00103-X.
McElvaney O, Hobbs B, Qiao D, McElvaney O, Moll M, McEvoy N EBioMedicine. 2020; 61:103026.
PMID: 33039714 PMC: 7543971. DOI: 10.1016/j.ebiom.2020.103026.
Shen Z, Lu J, Wei J, Zhao J, Wang M, Wang M Ann Transl Med. 2020; 7(22):664.
PMID: 31930065 PMC: 6944589. DOI: 10.21037/atm.2019.10.43.